MED20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.997600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.323400E-01
Normal-vs-Stage2
5.130600E-01
Normal-vs-Stage3
1.123580E-01
Normal-vs-Stage4
4.092600E-01
Stage1-vs-Stage2
9.211200E-01
Stage1-vs-Stage3
3.177800E-01
Stage1-vs-Stage4
1.800600E-01
Stage2-vs-Stage3
2.141600E-01
Stage2-vs-Stage4
1.084120E-02
Stage3-vs-Stage4
8.382100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.046800E-01
Normal-vs-AfricanAmerican
9.509200E-01
Normal-vs-Asian
4.613000E-01
Caucasian-vs-AfricanAmerican
5.211800E-01
Caucasian-vs-Asian
5.735600E-01
AfricanAmerican-vs-Asian
3.847800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.174600E-01
Normal-vs-Female
4.544000E-01
Male-vs-Female
2.496800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.888600E-01
Normal-vs-Age(41-60Yrs)
9.911400E-01
Normal-vs-Age(61-80Yrs)
3.920200E-01
Normal-vs-Age(81-100Yrs)
6.487000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.404800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.552400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.080000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.318000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.884600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.742600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.944600E-01
Normal-vs-Daily Drinker
1.626380E-01
Normal-vs-Weekly Drinker
4.242000E-01
Normal-vs-Occasional Drinker
8.411400E-01
Normal-vs-Social Drinker
3.729200E-01
Non Drinker-vs-Daily Drinker
1.563410E-01
Non Drinker-vs-Weekly Drinker
9.996200E-01
Non Drinker-vs-Occasional Drinker
9.578400E-02
Non Drinker-vs-Social Drinker
9.139200E-01
Daily Drinker-vs-Weekly Drinker
2.027200E-01
Daily Drinker-vs-Occasional Drinker
8.360200E-03
Daily Drinker-vs-Social Drinker
1.371380E-01
Weekly Drinker-vs-Occasional Drinker
1.543990E-01
Weekly Drinker-vs-Social Drinker
9.103000E-01
Occasional Drinker-vs-Social Drinker
1.310200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.676600E-01
Normal-vs-Grade 2
6.171400E-01
Normal-vs-Grade 3
1.608370E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.730200E-01
Grade 1-vs-Grade 3
2.175200E-01
Grade 1-vs-Grade 4
3.676600E-01
Grade 2-vs-Grade 3
3.885200E-01
Grade 2-vs-Grade 4
6.171400E-01
Grade 3-vs-Grade 4
1.608370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.622800E-01
Normal-vs-NonDiabetic
5.896800E-01
Diabetic-vs-NonDiabetic
1.392840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.028830E-01
Normal-vs-NoPancreatitis
5.558000E-01
Pancreatitis-vs-NoPancreatitis
2.248800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.119200E-01
Normal-vs-N1
5.604600E-01
N0-vs-N1
4.957000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.551400E-01
Normal-vs-TP53-NonMutant
7.365800E-01
TP53-Mutant-vs-TP53-NonMutant
8.200400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
